IP Strategies for Health Sciences Startups
发布时间 2014-04-07 15:47:44 来源
摘要
Biotech and medical device companies are heavily dependent on intellectual property rights, particularly those developing diagnostic, therapeutic or invasive products. The complexity of the technology and rapidly evolving legal landscape make the availability, validity and enforceability of biotech patents highly uncertain. This session, led by Michael Twomey, a patent attorney and partner at WilmerHale, will explore some of the basic IP questions facing health sciences startups.
Learn more about the Harvard Innovation Lab at http://i-lab.harvard.edu/ and follow us on Twitter at http://twitter.com/innovationlab and like us on Facebook at https://www.facebook.com/harvardinnovationlab
GPT-4正在为你翻译摘要中......
